{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:28:32Z","timestamp":1793035712884,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020295","name":"Natera","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.semnephrol.2023.151434","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T22:48:36Z","timestamp":1700693316000},"page":"151434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management"],"prefix":"10.1016","volume":"43","author":[{"given":"Christian","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioan-Andrei","family":"Iliuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad T.","family":"Chebib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0001","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0002","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/ndt\/gfy261","article-title":"Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease","volume":"34","author":"Lanktree","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0003","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.ajkd.2020.10.021","article-title":"Diagnosis and management of renal cystic disease of the newborn: core curriculum 2021","volume":"78","author":"Raina","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2020.08.012","article-title":"Ciliopathies and the kidney: a review","volume":"77","author":"McConnachie","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151434_bib0006","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00467-010-1731-7","article-title":"Ciliopathies: an expanding disease spectrum","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1399-0004.2008.01148.x","article-title":"Cystic kidney diseases and planar cell polarity signaling","volume":"75","author":"Bacallao","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0008","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamapediatrics.2017.3938","article-title":"Perinatal diagnosis, management, and follow-up of cystic renal diseases: a clinical practice recommendation with systematic literature reviews","volume":"172","author":"Gimpel","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1590\/1806-9282.60.01.004","article-title":"Hereditary polycystic kidney disease: genetic diagnosis and counseling","volume":"60","author":"Whittle","year":"2014","journal-title":"Rev Assoc Med Bras"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0011","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1542\/neo.23-3-e175","article-title":"Genetic etiologies, diagnosis, and management of neonatal cystic kidney disease","volume":"23","author":"Heidenreich","year":"2022","journal-title":"NeoReviews"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0012","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1038\/s41598-019-43488-w","article-title":"Clinical courses and complications of young adults with autosomal recessive polycystic kidney disease (ARPKD)","volume":"9","author":"Burgmaier","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0013","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151434_bib0014","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ng.3871","article-title":"Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease","volume":"49","author":"Lu","year":"2017","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/pd.5536","article-title":"Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT)","volume":"39","author":"Talati","year":"2019","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0016","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpeds.2014.06.015","article-title":"Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference","volume":"165","author":"Guay-Woodford","year":"2014","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151434_bib0018","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ymgme.2011.09.001","article-title":"Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease","volume":"104","author":"Gunay-Aygun","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.pap.0000201831.77472.d3","article-title":"Renal cystic diseases: a review","volume":"13","author":"Bisceglia","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670050281","article-title":"Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors","volume":"11","author":"Roy","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0021","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fped.2017.00272","article-title":"Is autosomal dominant polycystic kidney disease becoming a pediatric disorder?","volume":"5","author":"De Rechter","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0022","doi-asserted-by":"crossref","first-page":"441","DOI":"10.12659\/PJR.894482","article-title":"Diagnostic imaging of autosomal dominant polycystic kidney disease","volume":"81","author":"Gradzik","year":"2015","journal-title":"Pol J Radiol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/ajkd.2002.33908","article-title":"Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease","volume":"40","author":"Paterson","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151434_bib0024","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/uog.1098","article-title":"Prenatal sonographic patterns in autosomal dominant polycystic kidney disease: a multicenter study: prenatal sonography ADPKD","volume":"24","author":"Brun","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151434_bib0027","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1294-328","article-title":"Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2014a contiguous gene syndrome","volume":"8","author":"Brook-Carter","year":"1994","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0028","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/ckj\/sft162","article-title":"Renal manifestations of tuberous sclerosis among children: an Indian experience and review of the literature","volume":"7","author":"Korula","year":"2014","journal-title":"Clin Kidney J"},{"issue":"suppl_1","key":"10.1016\/j.semnephrol.2023.151434_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfy088","article-title":"Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective","volume":"11","author":"De Rechter","year":"2018","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-021-04974-4","article-title":"The wind of change in the management of autosomal dominant polycystic kidney disease in childhood","volume":"37","author":"Gimpel","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fped.2018.00023","article-title":"Managing Bardet\u2013Biedl syndrome\u2014now and in the future","volume":"6","author":"Forsythe","year":"2018","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0032","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00431-011-1553-z","article-title":"Educational paper: ciliopathies","volume":"171","author":"Bergmann","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"20","key":"10.1016\/j.semnephrol.2023.151434_bib0033","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1093\/hmg\/ddu267","article-title":"Bardet\u2013Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein","volume":"23","author":"Su","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0034","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00439-007-0341-3","article-title":"Molecular diagnostics of Meckel\u2013Gruber syndrome highlights phenotypic differences between MKS1 and MKS3","volume":"121","author":"Consugar","year":"2007","journal-title":"Hum Genet"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151434_bib0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.594","article-title":"Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes","volume":"42","author":"Valente","year":"2010","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0036","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/hmg\/ddt054","article-title":"The Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity","volume":"22","author":"Leightner","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0037","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201012116","article-title":"MKS and NPHP modules cooperate to establish basal body\/transition zone membrane associations and ciliary gate function during ciliogenesis","volume":"192","author":"Williams","year":"2011","journal-title":"J Cell Biol"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151434_bib0038","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00467-008-0840-z","article-title":"Nephronophthisis","volume":"24","author":"Salomon","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0039","series-title":"GeneReviews [Internet]","article-title":"Nephronophthisis","author":"Stokman","year":"2016"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.31963","article-title":"Genotype\u2013phenotype correlates in Joubert syndrome: a review","volume":"190","author":"Gana","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet."},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0041","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MOP.0000000000000194","article-title":"Nephronophthisis and related syndromes","volume":"27","author":"Wolf","year":"2015","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0042","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0272-6386(98)70083-6","article-title":"Renal-retinal syndromes: association of retinal anomalies and recessive nephronophthisis in patients with homozygous deletion of the NPH1 locus","volume":"32","author":"Caridi","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0043","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00431-009-0991-3","article-title":"Jeune syndrome: description of 13 cases and a proposal for follow-up protocol","volume":"169","author":"de Vries","year":"2010","journal-title":"Eur J Pediatr"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0044","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajhg.2013.10.003","article-title":"Mutations in the gene encoding IFT dynein complex component WDR34 cause Jeune asphyxiating thoracic dystrophy","volume":"93","author":"Schmidts","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0045","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00467-015-3142-2","article-title":"HNF1B-associated clinical phenotypes: the kidney and beyond","volume":"31","author":"Bockenhauer","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0046","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00467-009-1416-2","article-title":"Glomerulocystic kidney disease","volume":"25","author":"Bissler","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0047","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOP.0000000000000324","article-title":"Renal dysplasia in the neonate","volume":"28","author":"Phua","year":"2016","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151434_bib0048","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13312-014-0467-z","article-title":"Multicystic dysplastic kidney: a retrospective study","volume":"51","author":"Sharada","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0049","series-title":"Obstetric imaging: fetal diagnosis and care","first-page":"58","article-title":"Multicystic dysplastic kidney","author":"Bleich","year":"2018"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0050","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1681\/ASN.2005030239","article-title":"Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2","volume":"16","author":"Fletcher","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0051","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00467-010-1454-9","article-title":"HNF1B alterations associated with congenital anomalies of the kidney and urinary tract","volume":"25","author":"Nakayama","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0052","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ajmg.a.38324","article-title":"von Hippel-Lindau development in children and adolescents","volume":"173","author":"Launbjerg","year":"2017","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0053","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0036-1593841","article-title":"Ciliopathies: genetics in pediatric medicine","volume":"06","author":"Oud","year":"2016","journal-title":"J Pediatr Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0054","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12920-021-01084-w","article-title":"Whole genome sequencing in the diagnosis of primary ciliary dyskinesia","volume":"14","author":"Wheway","year":"2021","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41525-018-0049-4","article-title":"Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization","volume":"3","author":"Farnaes","year":"2018","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0056","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.3389\/bjbs.2021.10221","article-title":"Molecular diagnostics of ciliopathies and insights into novel developments in diagnosing rare diseases","volume":"79","author":"Modarage","year":"2022","journal-title":"Br J Biomed Sci"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0057","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00467-020-04562-y","article-title":"Continuous kidney replacement therapy in critically ill neonates and infants: a retrospective analysis of clinical results with a dedicated device","volume":"35","author":"Garzotto","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0058","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.05190422","article-title":"Perspectives on drug development in early ADPKD","volume":"17","author":"Mekahli","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151434_bib0059","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.02810608","article-title":"Prospective change in renal volume and function in children with ADPKD","volume":"4","author":"Cadnapaphornchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MOP.0000000000000195","article-title":"Autosomal dominant polycystic kidney disease in children","volume":"27","author":"Cadnapaphornchai","year":"2015","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0061","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.0000000000000022","article-title":"Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: randomized controlled trial","volume":"18","author":"Mekahli","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0062","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","article-title":"Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease","volume":"9","author":"Cadnapaphornchai","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0063","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151434_bib0064","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151434_bib0065","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2009020162","article-title":"Family history of renal disease severity predicts the mutated gene in ADPKD","volume":"20","author":"Barua","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0066","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0067","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0068","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0069","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0070","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.kint.2019.08.038","article-title":"Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease","volume":"97","author":"Hopp","year":"2020","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151434_bib0071","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.ekir.2019.04.018","article-title":"Intrafamilial variability of ADPKD","volume":"4","author":"Lanktree","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0072","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.kint.2020.02.022","article-title":"Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease","volume":"98","author":"Huynh","year":"2020","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0073","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/nep.13393","article-title":"Nephronophthisis: a review of genotype\u2013phenotype correlation","volume":"23","author":"Luo","year":"2018","journal-title":"Nephrology"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0074","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal dominant tubulointerstitial kidney disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0075","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ekir.2021.02.005","article-title":"Genetic background and clinicopathologic features of adult-onset nephronophthisis","volume":"6","author":"Fujimaru","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0076","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2023.151434_bib0077","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel\u2013Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0078","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0079","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2011.12.022","article-title":"Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors","volume":"59","author":"Rule","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0080","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2011101032","article-title":"Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing","volume":"23","author":"Rossetti","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0081","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jmoldx.2013.10.005","article-title":"Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing","volume":"16","author":"Tan","year":"2014","journal-title":"J Mol Diagn"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0082","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mgg3.82","article-title":"Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing","volume":"2","author":"Trujillano","year":"2014","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116680","article-title":"An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease","volume":"10","author":"Eisenberger","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0084","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/ejhg.2016.48","article-title":"Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease","volume":"24","author":"Mallawaarachchi","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151434_bib0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrneph.2014.95","article-title":"Next-generation sequencing for research and diagnostics in kidney disease","volume":"10","author":"Renkema","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0086","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fgene.2020.00464","article-title":"Gene panel analysis in a large cohort of patients with autosomal dominant polycystic kidney disease allows the identification of 80 potentially causative novel variants and the characterization of a complex genetic architecture in a subset of families","volume":"11","author":"Mantovani","year":"2020","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0087","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41431-020-00796-4","article-title":"Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing","volume":"29","author":"Mallawaarachchi","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151434_bib0088","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/s41436-020-0816-3","article-title":"Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes","volume":"22","author":"Sch\u00f6nauer","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0089","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.02320220","article-title":"Insights into autosomal dominant polycystic kidney disease from genetic studies","volume":"16","author":"Lanktree","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0091","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.2016090938","article-title":"Polycystic kidney disease without an apparent family history","volume":"28","author":"Iliuta","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0092","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1172\/JCI90129","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function","volume":"127","author":"Besse","year":"2017","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151434_bib0093","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2019030298","article-title":"ALG9 mutation carriers develop kidney and liver cysts","volume":"30","author":"Besse","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0094","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.semnephrol.2023.151434_bib0095","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ajhg.2022.06.013","article-title":"Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis","volume":"109","author":"Lemoine","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0096","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","article-title":"Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype","volume":"109","author":"Senum","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0097","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.34067\/KID.0007552021","article-title":"A practical guide to genetic testing for kidney disorders of unknown etiology","volume":"3","author":"Aron","year":"2022","journal-title":"Kidney360"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0098","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2215\/CJN.15141219","article-title":"Clinical genetic screening in adult patients with kidney disease","volume":"15","author":"Cocchi","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0099","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.04870422","article-title":"Perspectives on drug development in autosomal recessive polycystic kidney disease","volume":"17","author":"Liebau","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2023.151434_bib0100","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2215\/CJN.08150816","article-title":"Treatment of renal angiomyolipoma and other hamartomas in patients with tuberous sclerosis complex","volume":"12","author":"Samuels","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0101","first-page":"1","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan","year":"2022","journal-title":"N Engl J Med Evid"},{"issue":"18","key":"10.1016\/j.semnephrol.2023.151434_bib0102","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2018.4930","article-title":"Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease: the CKD WIT randomized clinical trial","volume":"319","author":"Clark","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151434_bib0103","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2215\/CJN.03960318","article-title":"Recent advances in the management of autosomal dominant polycystic kidney disease","volume":"13","author":"Chebib","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.semnephrol.2023.151434_bib0104","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.semnephrol.2023.151434_bib0105","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.semnephrol.2023.151434_bib0106","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0107","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0108","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0109","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.02650313","article-title":"Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study","volume":"9","author":"Braun","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2023.151434_bib0110","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/ndt\/gfs264","article-title":"Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study","volume":"27","author":"Stallone","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0111","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0112","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.09900915","article-title":"Effect of sirolimus on disease progression in patients with autosomal dominant polycystic kidney disease and CKD stages 3b-4","volume":"11","author":"Ruggenenti","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.semnephrol.2023.151434_bib0113","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.2018.15870","article-title":"Effect of lanreotide on kidney function in patients with autosomal dominant polycystic kidney disease: the DIPAK 1 randomized clinical trial","volume":"320","author":"Meijer","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151434_bib0114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002777","article-title":"Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): a randomized, double-blind, placebo-controlled, multicenter trial","volume":"16","author":"Perico","year":"2019","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2021.06.013","article-title":"Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)","volume":"100","author":"Perrone","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151434_bib0116","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/j.ajkd.2021.06.026","article-title":"Metformin therapy in autosomal dominant polycystic kidney disease: a feasibility study","volume":"79","author":"Brosnahan","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0117","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40265-022-01745-9","article-title":"Drugs in clinical development to treat autosomal dominant polycystic kidney disease","volume":"82","author":"Bais","year":"2022","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.semnephrol.2023.151434_bib0118","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40620-019-00679-y","article-title":"ADPKD current management and ongoing trials","volume":"33","author":"Testa","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2023.151434_bib0119","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfab312","volume":"37","author":"M\u00fcller","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2023.151434_bib0120","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.2018060590","article-title":"A practical guide for treatment of rapidly progressive ADPKD with tolvaptan","volume":"29","author":"Chebib","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0121","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2023.151434_bib0122","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","article-title":"International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people","volume":"15","author":"Gimpel","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0123","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0033-8389(22)00680-7","article-title":"Acquired cystic kidney disease","volume":"34","author":"Levine","year":"1996","journal-title":"Radiol Clin North Am"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0124","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0272-6386(87)80098-7","article-title":"Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy","volume":"10","author":"Boton","year":"1987","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2023.151434_bib0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000447208","article-title":"Efficacy of multi-detector computed tomography for the diagnosis of medullary sponge kidney","volume":"11","author":"Gaunay","year":"2018","journal-title":"Curr Urol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0126","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.2214\/AJR.15.14548","article-title":"Multilocular cystic nephroma: a systematic literature review of the radiologic and clinical findings","volume":"205","author":"Granja","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0127","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0128","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1681\/ASN.2017111200","article-title":"NPHP1 (nephrocystin-1) gene deletions cause adult-onset ESRD","volume":"29","author":"Snoek","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2023.151434_bib0129","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1681\/ASN.2018040441","article-title":"The underestimated burden of monogenic diseases in adult-onset ESRD","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2023.151434_bib0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00467-010-1746-0","article-title":"Long-term risk of chronic kidney disease in unilateral multicystic dysplastic kidney","volume":"26","author":"Mansoor","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2023.151434_bib0131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2023.151434_bib0132","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.kint.2023.07.021","article-title":"Certain heterozygous variants in the kinase domain of the serine\/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease","volume":"104","author":"Claus","year":"2023","journal-title":"Kidney Int."}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929523001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:49:48Z","timestamp":1748357388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929523001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0270929523001444"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151434","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Kidney Diseases in Children and Adults: Differences and Gaps in Clinical Management","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151434"}}